Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
- USD | -.--% |
|
-0,07 % | +269,92 % |
2019 | Transcript : Dova Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 06, 2019 | |
2019 | Transcript : Dova Pharmaceuticals, Inc. - Special Call |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mahmood Ladha
PSD | President | 60 | 12/11/19 |
Lee F. Allen
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/04/17 |
Marc Banjak
LAW | General Counsel | - | - |
Bill L. Nichols
SAM | Sales & Marketing | - | 15/02/18 |
Stephen Crane
SAM | Sales & Marketing | - | - |
Caroline Diaz
LAW | General Counsel | - | - |
Corporate Secretary | 49 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Henrik Stenqvist
BRD | Director/Board Member | 57 | 12/11/19 |
Guido Oelkers
BRD | Director/Board Member | 59 | 12/11/19 |
Director/Board Member | 55 | 12/11/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 28 821 405 | 13 851 527 ( 48,06 %) | 0 | 48,06 % |
Información de la empresa
Dova Pharmaceuticals, Inc.
240 Leigh Farm Road Suite 245
27707, Durham
+919-748-5975
http://www.dova.com![Dirección Dova Pharmaceuticals, Inc.(DOVA)](https://cdn.zonebourse.com/static/address/35952873.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+269,92 % | 808 M | |
+15,39 % | 121 mil M | |
+19,68 % | 113 mil M | |
+17,47 % | 26,02 mil M | |
-25,36 % | 19,39 mil M | |
-19,51 % | 15,91 mil M | |
-19,10 % | 15,09 mil M | |
-46,87 % | 15,06 mil M | |
+63,23 % | 14,93 mil M | |
+5,69 % | 13,85 mil M |
- Bolsa de valores
- Acciones
- Acción DOVA
- Empresa Dova Pharmaceuticals, Inc.